FR2414914A1 - Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine - Google Patents

Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine

Info

Publication number
FR2414914A1
FR2414914A1 FR7832407A FR7832407A FR2414914A1 FR 2414914 A1 FR2414914 A1 FR 2414914A1 FR 7832407 A FR7832407 A FR 7832407A FR 7832407 A FR7832407 A FR 7832407A FR 2414914 A1 FR2414914 A1 FR 2414914A1
Authority
FR
France
Prior art keywords
derivs
carnitine
acylated
ischaemia
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7832407A
Other languages
English (en)
Other versions
FR2414914B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT4767678A external-priority patent/IT1155772B/it
Priority claimed from IT4789978A external-priority patent/IT1155814B/it
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of FR2414914A1 publication Critical patent/FR2414914A1/fr
Application granted granted Critical
Publication of FR2414914B1 publication Critical patent/FR2414914B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

a. L'invention concerne un procédé nouveau pour la thérapie cardiaque. b. Ce procédé est caractérisé en ce qu'on utilise, comme produit actif, l'acétyl-1-carnitine et d'autres dérivés de la 1-carnitine ainsi que leurs sels admissibles comme produits pharmaceutiques. c. Ces nouveaux médicaments font preuve d'une bonne activité pour la thérapie de l'anoxie du muscle cardiaque, de l'ischémie, des insuffisances cardiaques et autres.
FR7832407A 1978-01-18 1978-11-16 Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine Granted FR2414914A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4767678A IT1155772B (it) 1978-01-18 1978-01-18 Applicazione terapeutica del l'acetil-i-carnitina e di altri derivati acilati della i-carnitina
IT4789978A IT1155814B (it) 1978-02-03 1978-02-03 Nouva applicazione terapeutica dell'acetil-i-carnitina e di altri derivati acilati della i-carnitina

Publications (2)

Publication Number Publication Date
FR2414914A1 true FR2414914A1 (fr) 1979-08-17
FR2414914B1 FR2414914B1 (fr) 1983-04-15

Family

ID=26329217

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7832407A Granted FR2414914A1 (fr) 1978-01-18 1978-11-16 Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine

Country Status (1)

Country Link
FR (1) FR2414914A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2425855A1 (fr) * 1978-05-15 1979-12-14 Cavazza Claudio Application des acyl-carnitines a un procede therapeutique de traitement de patients uremiques chroniques en traitement hemodialytique periodique et composition liquide de dialyse pour la mise en oeuvre d'un tel procede
FR2448347A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement des maladies vasculaires peripheriques
FR2448348A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement du metabolisme cerebral perturbe
FR2482588A1 (fr) * 1980-05-15 1981-11-20 Sigma Tau Ind Farmaceuti Composition pharmaceutique pour le traitement du diabete sucre juvenile

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1573430A (fr) * 1967-07-03 1969-07-04
JPS4980272A (fr) * 1972-12-08 1974-08-02
DE2817358A1 (de) * 1977-04-29 1978-11-02 Sigma Tau Ind Farmaceuti Neue therapeutische anwendung von acylderivaten des d,l-carnitin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1573430A (fr) * 1967-07-03 1969-07-04
JPS4980272A (fr) * 1972-12-08 1974-08-02
DE2817358A1 (de) * 1977-04-29 1978-11-02 Sigma Tau Ind Farmaceuti Neue therapeutische anwendung von acylderivaten des d,l-carnitin
FR2388556A1 (fr) * 1977-04-29 1978-11-24 Sigma Tau Ind Farmaceuti Application therapeutique de l'acetyl-carnitine-d,1 et d'autres derives acyliques de la carnitine-d,1

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1975 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2425855A1 (fr) * 1978-05-15 1979-12-14 Cavazza Claudio Application des acyl-carnitines a un procede therapeutique de traitement de patients uremiques chroniques en traitement hemodialytique periodique et composition liquide de dialyse pour la mise en oeuvre d'un tel procede
FR2448347A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement des maladies vasculaires peripheriques
FR2448348A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement du metabolisme cerebral perturbe
FR2482588A1 (fr) * 1980-05-15 1981-11-20 Sigma Tau Ind Farmaceuti Composition pharmaceutique pour le traitement du diabete sucre juvenile

Also Published As

Publication number Publication date
FR2414914B1 (fr) 1983-04-15

Similar Documents

Publication Publication Date Title
JPS5665892A (en) 6 betaahydroxyalkylpenicillaic acid derivative as betaalactamase inhibitor
DE3370626D1 (en) Imidazolylalkylthienyl-tetrahydropyridazines and process for their preparation
ATE674T1 (de) Pulveranstrichmittel, verfahren zu seiner herstellung und damit ueberzogene gegenstaende.
DE2963267D1 (en) 2-hydroxybutanesulfonic acid choline and its use as conducting salt
GB1521926A (en) N,n'-di-(hydroxybenzyl)-1,3-propane and 1,3-propane-2-ol-diamine-n,n'-diacetic acids their salts and metal chelates
DE3562232D1 (en) New derivatives of l-carnitine
FR2414914A1 (fr) Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine
IL70352A (en) L-beta-hydroxy-epsilon-substituted butryic acid derivatives,enzymatic process for preparing them and their use for preparing l-carnitine
IT1062549B (it) Processo per la preparazione di nitrili insaturi
IT1155772B (it) Applicazione terapeutica del l'acetil-i-carnitina e di altri derivati acilati della i-carnitina
IT1155814B (it) Nouva applicazione terapeutica dell'acetil-i-carnitina e di altri derivati acilati della i-carnitina
JPS5353636A (en) Preparatin of highly pure aromatic dicarboxylic acid dichloride
ZA803393B (en) Process for the preparation of 4,4'-dinitrostilbene-2,2'-disulfonic acid and its salts
CA2138153A1 (fr) Preparation electrochimique d'acides dicarboxyliques
IT1119854B (it) Composizione farmaceutica comprendente l-carnitina per il trattamento di disfunzioni cardiache
ES459423A1 (es) Procedimiento para la obtencion de derivados de la vincaminay de la apovincamina.
GB2008578A (en) I-Carnitine derivatives
PT81568A (en) Process for the preparation of new esthers of ascorbic acid or long chain saturated aliphatic acids used as surfactants
JPS56120662A (en) Novel nitrosourea derivative and its preparation
WO2000030637A8 (fr) Utilisation d'un sel de fumarate de l carnitine, ou de ses derives alcanoyles, pour lutter contre l'ischemie
GB1538937A (en) Treatment of 1,5-dimethyl-tetralin to remove acid residues therefrom
GB2059948B (en) Aluminium-gluconic acid complex corrosion inhibitor
PT83192B (en) Process for preparing unsaturated compounds useful in the treatment of cardiovascular phatological conditions containing 1,4-di-hydropiridine-3,5-dicarboxylic acid derivatives
JPS5441329A (en) Agent for promoting breeding of animal
JPS5589244A (en) Ammonium salt of alphaaketocarboxylic acid